Quick Answer
INCYTE CORP reported Total Revenue of $5.14 billion for fiscal year 2025.
INCYTE CORP — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | $5.14B +21.2% |
$4.24B +14.8% |
$3.70B +8.9% |
$3.39B +13.7% |
$2.99B +12.0% |
$2.67B +23.5% |
| Revenue (ASC 606) | $5.14B +21.2% |
$4.24B +14.8% |
$3.70B +8.9% |
$3.39B +13.7% |
$2.99B | — |
| Net Income | $1.29B +3845.0% |
$32.62M -94.5% |
$597.60M +75.4% |
$340.66M -64.1% |
$948.58M +420.8% |
-$295.70M -166.2% |
| Diluted EPS | $6.41 +4173.3% |
$0.15 -94.3% |
$2.65 +74.3% |
$1.52 -64.4% |
$4.27 +414.0% |
-$1.36 -166.3% |
| Total Assets | $6.96B +27.8% |
$5.44B -19.7% |
$6.78B +16.1% |
$5.84B +18.4% |
$4.93B +38.5% |
$3.56B +3.9% |
| Cash and Equivalents | $3.10B +83.5% |
$1.69B -47.5% |
$3.21B +8.9% |
$2.95B +43.5% |
$2.06B +36.0% |
$1.51B -17.4% |
| Stockholders Equity | $5.17B +49.9% |
$3.45B -33.6% |
$5.19B +18.8% |
$4.37B +15.9% |
$3.77B +44.4% |
$2.61B +0.5% |
| R&D Expense | $2.05B -21.4% |
$2.61B +60.2% |
$1.63B +2.6% |
$1.59B +8.8% |
$1.46B -34.2% |
$2.22B +92.0% |
| Operating Income | $1.51B +2368.6% |
$61.37M -90.1% |
$620.52M +7.1% |
$579.44M -1.1% |
$585.78M +322.2% |
-$263.68M -165.6% |
| Shares Outstanding | 198.46M +2.6% |
193.43M -13.8% |
224.29M +0.7% |
222.75M +0.8% |
221.08M +0.7% |
219.49M +1.5% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2025 | $1.37B | +20.0% | +12.4% |
| Revenue (ASC 606) | September 30, 2025 | $1.37B | +20.0% | +12.4% |
| Net Income | September 30, 2025 | $424.17M | +298.4% | +4.7% |
| Diluted EPS | September 30, 2025 | $2.11 | +290.7% | +3.4% |
| Total Assets | September 30, 2025 | $6.33B | +26.3% | +8.7% |
| Cash and Equivalents | September 30, 2025 | $2.46B | +88.3% | +25.6% |
| Stockholders Equity | September 30, 2025 | $4.65B | +46.7% | +11.5% |
| R&D Expense | September 30, 2025 | $506.58M | -11.6% | +2.4% |
| Operating Income | September 30, 2025 | $443.52M | +203.6% | -16.4% |
| Shares Outstanding | September 30, 2025 | 196.13M | +1.7% | +1.0% |
- INCYTE CORP reported Total Revenue of $5.14 billion for fiscal year 2025.
- INCYTE CORP showed an increase of +21.2% in Total Revenue compared to the prior fiscal year.
- INCYTE CORP reported Revenue (ASC 606) of $5.14 billion for fiscal year 2025.
- INCYTE CORP showed an increase of +21.2% in Revenue (ASC 606) compared to the prior fiscal year.
- INCYTE CORP reported Net Income of $1.29 billion for fiscal year 2025.
- INCYTE CORP showed an increase of +3845.0% in Net Income compared to the prior fiscal year.
- INCYTE CORP reported Diluted EPS of $6.41 per share for fiscal year 2025.
- INCYTE CORP showed an increase of +4173.3% in Diluted EPS compared to the prior fiscal year.
- INCYTE CORP reported Total Assets of $6.96 billion for fiscal year 2025.
- INCYTE CORP showed an increase of +27.8% in Total Assets compared to the prior fiscal year.
- INCYTE CORP reported Cash and Equivalents of $3.10 billion for fiscal year 2025.
- INCYTE CORP showed an increase of +83.5% in Cash and Equivalents compared to the prior fiscal year.
- INCYTE CORP reported Stockholders Equity of $5.17 billion for fiscal year 2025.
- INCYTE CORP showed an increase of +49.9% in Stockholders Equity compared to the prior fiscal year.
- INCYTE CORP reported R&D Expense of $2.05 billion for fiscal year 2025.
- INCYTE CORP showed a decrease of -21.4% in R&D Expense compared to the prior fiscal year.
- INCYTE CORP reported Operating Income of $1.51 billion for fiscal year 2025.
- INCYTE CORP showed an increase of +2368.6% in Operating Income compared to the prior fiscal year.
- INCYTE CORP reported Shares Outstanding of 198.46 million shares for fiscal year 2025.
- INCYTE CORP showed an increase of +2.6% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: